Epidemiology and course of acute upper gastro-intestinal haemorrhage in four French geographical areas

Citation
P. Czernichow et al., Epidemiology and course of acute upper gastro-intestinal haemorrhage in four French geographical areas, EUR J GASTR, 12(2), 2000, pp. 175-181
Citations number
15
Categorie Soggetti
Gastroenerology and Hepatology
Journal title
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY
ISSN journal
0954691X → ACNP
Volume
12
Issue
2
Year of publication
2000
Pages
175 - 181
Database
ISI
SICI code
0954-691X(200002)12:2<175:EACOAU>2.0.ZU;2-L
Abstract
Objective To compare incidence rates and epidemiological characteristics of acute upper gastrointestinal haemorrhage (AUGIH) in France with those of o ther European studies. Design Population-based multi-centre prospective survey. Setting 29 public hospitals and 96 private specialists in gastroenterology in four administrative areas in France during 1996. Subjects A total of 2133 AUGIH patients 18 years and over were included in the six-month study. Outcome measures Incidence and mortality, Results The overall incidence in France was 143 cases per 100 000 persons p er year, classified as out-patients (16%), emergency admissions (59%) and i n-patients (25%). The incidence rates increased with age except for in-pati ents, and were higher in males. Peptic ulcer (36.6%), varices (13.7%) and e rosive disease (12.3%) were the most frequent diagnoses, In 677 patients (3 1.7%), aspirin, antiinflammatory drugs or corticosteroids were taken on the 7 days before bleeding. The overall mortality tout-patients excluded) was 14.3% (10.7% for emergency patients and 23% for in-patients). Mortality was associated with comorbidities (especially malignancies, cirrhosis, asthma or respiratory deficiency), was lower in emergency patients using non-stero id anti-inflammatory drugs, and higher in in-patients using corticosteroids . Conclusions In France, patients with AUGIH are frequently managed as out-pa tients. Gastrotoxic drug use is frequently associated with AUGIH and consti tutes a strategic opportunity for preventive treatment. Discrepancies betwe en countries are not clearly explained either by demographic factors or by drug use, but this may be related to the emphasis on AUGIH in in-patients. Eur J Gastroenterol Hepatol 12:175-181 (C) 2000 Lippincott Williams & Wilki ns.